Research Projects & Grants

For Profit Organization

  • A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People >/= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection, Role: Investigational Pharmacist, Gilead Sciences, Inc, (07/2024 - 07/2025) Status: Approved
  • A Phase I, Randomized, Open-Label, Active Controlled, Multi-Center Pilot Study to Compare Reference to Reference Pharmacodynamics of BOTOX® (onabotulinumtoxinA) in Healthy Subjects. Protocol: MR 103A-0I-IPS-1001. lnformed Consent Form Version Dated 25 November 2022., Role: Investigational Pharmacist, Mylan Pharmaceuticals, (11/2023 - 03/2024) Status: Completed
  • Effectiveness of semaglutide 2.4 mg vs. commercially available medications for chronic weight management in participants with obesity in a multi-employer setting in the US – a pragmatic clinical study (POSEY), Role: Research Coordinator/Nurse, Novo Nordisk Pharmaceuticals Inc., (10/2022) Status: Approved
  • Use of the Guardian™ Connect system with Smart Connected Devices: CIP 331, Role: Research Coordinator/Nurse, Medtronic, Inc., Status: Completed
  • ABC [Afrezza with Basal Combination]: A Phase 4 Study of Mealtime Control with Afrezza in Adult Subjects with Type I Diabetes Mellitus in Combination with an Automated Insulin Pump or Insulin Degludec, Role: Investigator, MannKind Corporation, Status: Completed
  • INHALE-3: A 17-Week Randomized Trial and a 13-Week Extension, Evaluating the Efficacy and Safety of Inhaled Insulin (Afrezza® ) Combined with Insulin Degludec Versus Usual Care in Adults with Type 1 Diabetes, Role: Investigator, MannKind Corporation, Status: Completed
  • IMPACT2: In-Home Study with MiniMed™ 780G Pump Automated Control in Type 2 - Evaluation of the AHCL System Insulin-requiring Type 2 Diabetes, Role: Research Tech/Assistant, Medtronic, Inc., (04/2025) Status: Completed

Internal

  • Evaluation of the health and economic outcomes following the integration of a pharmacist managed Diabetes clinic within a primary care setting, Role: Investigator, LLU Dept. of Pharmaceutical Sciences, (02/2022) Status: Approved